Issue Date: August 12, 2013
Roche Grants License For Eye Disease Drug
Roche and the Medicines Patent Pool have inked a supply agreement for Valcyte, an oral treatment for cytomegalovirus, a viral infection that can cause blindness and affects roughly one in 10 people living with HIV in low- and middle-income countries. Medicines Patent Pool is a United Nations-backed mechanism that lowers HIV drug prices by making patent licenses available to generic drug firms. Under the pact, Valcyte will be available . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society